AstraZeneca India Pharma on Thursday said it has received approval from the government authority for the import, sale, and distribution of a medication used in treating non-small cell lung cancer ...

A Google Translate screenshot correctly shows that the name of the pharmaceutical company AstraZeneca, when written as “A stra ze neca,” means “a road to death” in Latin. We reached out to ...

AstraZeneca has opened its first U.S.-operated cell therapy manufacturing plant in Rockville, Maryland, as part of its ongoing $3.5 billion investment in American innovation.

AstraZeneca AZN-1.52%decrease; red down pointing triangle plans to invest $2.5 billion in China over five years to build a research-and-development center and strike deals with local biotechnology ...

Why Britain failed to close £450m AstraZeneca deal. Collapse of plan to expand Liverpool vaccine factory is a 'blow' to Rachel Reeves' growth agenda. Newsletter sign up Newsletter; ...

British drugmaker AstraZeneca has appointed a new China head, replacing a former executive who has been detained by authorities in the country. Iskra Reic, who oversaw the development of the firm ...

AstraZeneca remains one of the best bets in Big Pharma, and potential success in obesity isn’t priced in to the stock. By . David Wainer. Share. Resize. Listen (3 min) ...

According to the Telegraph, AstraZeneca admitted for the first time in court documents that its COVID-19 vaccine can cause rare side effects such as blood clots and low blood platelet counts.

AstraZeneca has admitted in court documents that its COVID-19 vaccine could cause a rare but deadly blood-clotting condition, potentially exposing the UK pharmaceutical giant to tens of millions ...

AstraZeneca ADRs were up 5.6% to $75.20 as of noon ET and have gained nearly 12% so far this year. They reached their all-time high of $76.56 precisely one year ago. Article Sources ...

AstraZeneca is adding to the explosion of interest in radiopharmaceuticals, inking a $2 billion buyout to meld Fusion Pharmaceuticals with its cancer unit. Fusion’s pipeline is led by a PSMA ...

AstraZeneca could pay an additional $5 per share depending on the progress of Icosavax’s vaccine candidates. That payout could bring the value of the deal to $1.1 billion. Sponsored Post ...